Ligand Pharmaceuticals Income Statement (2010-2025) | LGND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	0.05B	0.08B	0.06B	0.06B	0.04B	0.05B	0.06B	0.05B	0.04B	0.03B	0.03B	0.03B	0.03B	0.04B	0.05B	0.04B	0.05B	0.05B	0.12B	0.06B
Cost of Revenue (Quarter)	0.01B	0.03B	0.01B	0.01B	0.00B	0.01B	0.01B	0.02B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Gross Profit (Quarter)	0.04B	0.05B	0.05B	0.04B	0.03B	0.04B	0.05B	0.03B	0.04B	0.02B	0.03B	0.03B	0.03B	0.04B	0.05B	0.04B	0.04B	0.04B	0.11B	0.06B
Operating items
Amortization - Intangibles (Quarter)	0.01B	0.01B	0.01B	-0.00B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B
Research & Development (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.00B	0.05B	0.01B	0.02B	0.00B
Selling, General & Administrative (Quarter)	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.03B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.03B	0.02B	0.02B	0.03B	0.03B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	0.02B	0.03B	0.00B	-0.04B	0.01B				0.01B	0.01B	0.00B		0.01B	0.04B			0.01B	0.01B	0.01B	0.02B
Operating Expenses (Quarter)	0.04B	0.02B	0.03B	0.04B	0.03B	0.04B	0.05B	0.07B	0.03B	0.03B	0.03B	0.03B	0.03B	0.06B	0.05B	0.05B	0.08B	0.04B	0.06B	0.05B
Operating Income (Quarter)	0.00B	0.05B	0.02B	0.04B	0.00B	0.01B	0.01B	-0.02B	0.01B	-0.00B	0.00B	-0.00B	0.00B	-0.02B	0.00B	-0.01B	-0.04B	0.01B	0.05B	0.01B
EBIT (Quarter)	0.00B	0.05B	0.02B	0.04B	0.00B	0.01B	0.01B	-0.02B	0.01B	-0.00B	0.00B	-0.00B	0.00B	-0.02B	0.00B	-0.01B	-0.04B	0.01B	0.05B	0.01B
Non-operating items
Non Operating Investment Income (Quarter)	0.01B	-0.01B	0.00B	-0.01B	-0.01B	-0.00B	-0.00B	0.04B	0.04B	0.00B	-0.01B	0.02B	0.11B	-0.01B	0.00B	-0.02B	-0.01B	0.00B	0.01B	0.02B
Interest & Investment Income (Quarter)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B
Other Non Operating Income (Quarter)	-0.01B	-0.00B	0.00B	0.01B	0.00B	0.00B	0.00B	-0.00B		-0.00B	-0.00B			-0.03B	-0.01B	-0.01B	0.00B	0.00B	0.00B	0.00B
Non Operating Income (Quarter)	0.00B	-0.00B	-0.00B	-0.02B	-0.01B	-0.00B	0.00B	-0.00B	0.00B	0.01B	-0.02B	0.00B	0.11B	-0.05B	-0.01B	-0.01B	-0.00B	0.00B	0.09B	0.00B
Net income details
EBT (Quarter)	0.01B	0.03B	0.02B	0.02B	-0.01B	0.01B	0.01B	0.02B	0.06B	0.00B	-0.01B	0.02B	0.11B	-0.07B	-0.01B	-0.04B	-0.05B	0.01B	0.14B	0.06B
Tax Provisions (Quarter)	-0.01B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.04B	0.01B	0.00B	-0.00B	-0.00B	0.03B	-0.01B	0.00B	-0.01B	-0.01B	0.01B	0.02B	0.01B
Profit After Tax (Quarter)	0.02B	0.03B	0.01B	-0.00B	-0.02B	-0.00B	0.00B	-0.02B	0.04B	0.00B	-0.01B	0.02B	0.09B	-0.05B	-0.01B	-0.03B	-0.04B	-0.00B	0.12B	0.04B
Equity Income (Quarter)
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	0.02B	0.03B	0.01B	0.01B	-0.01B	0.01B	0.01B	-0.01B	0.04B	0.00B	-0.01B	0.02B	0.09B	-0.05B	-0.01B	-0.03B	-0.04B	0.00B	0.12B	0.04B
Consolidated Net Income (Quarter)	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B							-0.03B	-0.04B	0.00B	0.12B	0.04B
Income towards Parent Company (Quarter)	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B							-0.03B	-0.04B	0.00B	0.12B	0.04B
Net Income towards Common Stockholders (Quarter)	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B	-0.01B	-0.01B	-0.00B	-0.00B							-0.03B	-0.04B	0.00B	0.12B	0.04B
Additional items
EPS (Basic) (Quarter)	1.39	2.19	1.22	-0.19	-0.77	0.75	0.57	-0.86	2.46	0.13	-0.59	0.95	4.86	-2.88	-0.39	-1.72	-2.21	0.25	5.99	2.33
EPS (Weighted Average and Diluted) (Quarter)	1.32	2.12	1.19	-0.19	-0.77	0.74	0.56	-0.86	2.43	0.13	-0.59	0.94	4.75	-2.88	-0.39	-1.68	-2.21	0.24	5.68	2.18
Shares Outstanding (Weighted Average) (Quarter)	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
Shares Outstanding (Diluted Average) (Quarter)	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B
EBITDA (Quarter)	0.00B	0.05B	0.02B	0.04B	0.00B	0.01B	0.01B	-0.02B	0.01B	-0.00B	0.00B	-0.00B	0.00B	-0.02B	0.00B	-0.01B	-0.04B	0.01B	0.05B	0.01B
Interest Expenses (Quarter)	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Tax Rate (Quarter)	-214.12%	7.74%	10.07%	22.83%	-41.39%	-45.47%	21.93%	160.21%	21.47%	27.78%	15.41%	-6.38%	24.07%	20.61%	-13.14%	20.69%	15.40%	56.81%	16.91%	21.13%

Research Tools

Ligand Pharmaceuticals Income Statement (2010-2025) | LGND

Create an account

Sign In

Reset Password